Dr Sabry has been a strategic advisor and member of the board of directors since March 2008. Dr Sabry succeeds Dinesh Patel in the position of president and CEO, who will remain as a consultant to the company.
Dr Sabry is chairman of the board of directors and former CEO of Cytokinetics, a company he co-founded in August 1997. Dr Sabry has received an MD from Queen’s University and a PhD in cell biology from the University of California, San Francisco.
James Topper, chairman of the board of Arete, said: “We are confident that his exceptional entrepreneurial leadership will guide the company in the years to come as Arete continues to advance its pipeline of innovative compounds through clinical development.”